[국제]South Africa to start vaccinating next week with Johnson & Johnson vaccine instead of AstraZeneca

[국제]South Africa to start vaccinating next week with Johnson & Johnson vaccine instead of AstraZeneca

by

[앵커]

South Africa, which has decided not to use AstraZeneca’s COVID-19 vaccine, has decided to inoculate Johnson & Johnson’s vaccine, which has not yet been approved for use worldwide.

The vaccination is scheduled to begin next week.

Reporter Won-bae Kim reports.

[기자]

South Africa’s Health Minister Zwelly Mkize announced that the first phase of COVID-19 vaccination would continue using the Johnson & Johnson vaccine instead of the AstraZeneca vaccine.

[즈웰리 음키제 / 남아공 보건부 장관 : 아스트라제네카 대신 존슨앤드존슨의 백신을 사용해 보건 직원들을 대상으로 계획된 1단계 백신 접종을 계속할 것입니다.]

South Africa announced on the 7th that AstraZeneca’s COVID-19 vaccine had limited efficacy against a mutant virus from South Africa, and it stopped distribution of the vaccine.

Minister Mkije said Johnson & Johnson’s COVID-19 vaccine has been proven to be effective against mutant viruses originating in South Africa.

According to Reuters, the Johnson & Johnson vaccine was found to be 89% effective in preventing severe diseases and 57% of moderate to severe diseases in South Africa during global clinical trials.

However, no country has yet approved the Johnson & Johnson vaccine.

The South African government will cooperate with the South African Medical Research Council to inoculate the Johnson & Johnson vaccine in the form of research from health staff.

Secretary Mkise said he will start vaccinating next week.

Johnson & Johnson’s COVID-19 vaccine is expected to arrive in South Africa sometime next week.

This is YTN Kim Won-bae.

[저작권자(c) YTN & YTN plus 무단전재 및 재배포 금지]

.Source